Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU

NCT00048750 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

104

Enrollment

INDUSTRY

Sponsor class

Stopped Inadequate enrollment

Conditions

Invasive Fungal Infections

Interventions

DRUG: Micafungin
DRUG: Placebo

Sponsor

Astellas Pharma Inc